Credit Suisse Group AG restated their hold rating on shares of Humana Inc. (NYSE:HUM) in a research report sent to investors on Tuesday. They currently have a $188.00 price objective on the insurance provider’s stock.

Other research analysts also recently issued research reports about the stock. Cantor Fitzgerald restated a buy rating on shares of Humana in a report on Saturday, July 9th. Morgan Stanley restated a hold rating on shares of Humana in a report on Sunday, May 22nd. RBC Capital Markets restated a buy rating and set a $224.00 price objective (up previously from $220.00) on shares of Humana in a report on Friday, July 22nd. Jefferies Group restated a buy rating and set a $220.00 price objective (up previously from $210.00) on shares of Humana in a report on Monday, July 25th. Finally, Barclays PLC lowered their price objective on shares of Humana from $193.00 to $191.00 and set an equal weight rating on the stock in a report on Thursday, August 4th. Five investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock presently has an average rating of Buy and an average target price of $201.00.

Shares of Humana (NYSE:HUM) opened at 174.62 on Tuesday. Humana has a one year low of $150.00 and a one year high of $191.65. The company has a market cap of $26.03 billion, a P/E ratio of 26.83 and a beta of 0.91. The company’s 50 day moving average is $176.84 and its 200 day moving average is $176.92.

Humana (NYSE:HUM) last released its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The company had revenue of $14 billion for the quarter, compared to the consensus estimate of $13.59 billion. During the same quarter in the previous year, the company earned $1.67 EPS. Humana’s quarterly revenue was up 2.0% compared to the same quarter last year. On average, equities analysts predict that Humana will post $9.26 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be given a dividend of $0.29 per share. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a yield of 0.66%. Humana’s dividend payout ratio is presently 18.18%.

A number of institutional investors have recently modified their holdings of the company. Rehmann Capital Advisory Group raised its position in shares of Humana by 0.4% in the first quarter. Rehmann Capital Advisory Group now owns 1,506 shares of the insurance provider’s stock worth $276,000 after buying an additional 6 shares in the last quarter. First Republic Investment Management Inc. raised its position in shares of Humana by 1.8% in the first quarter. First Republic Investment Management Inc. now owns 1,145 shares of the insurance provider’s stock worth $209,000 after buying an additional 20 shares in the last quarter. Northwestern Mutual Investment Management Company LLC raised its position in shares of Humana by 0.4% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 5,684 shares of the insurance provider’s stock worth $1,022,000 after buying an additional 22 shares in the last quarter. Fifth Third Bancorp raised its position in shares of Humana by 0.5% in the second quarter. Fifth Third Bancorp now owns 4,547 shares of the insurance provider’s stock worth $818,000 after buying an additional 23 shares in the last quarter. Finally, Savant Capital LLC raised its position in shares of Humana by 1.3% in the second quarter. Savant Capital LLC now owns 2,380 shares of the insurance provider’s stock worth $428,000 after buying an additional 30 shares in the last quarter. Hedge funds and other institutional investors own 93.37% of the company’s stock.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.